Efficacy of Janus kinase inhibitors in rheumatoid arthritis

被引：0
|
作者：
Camille Langbour
Jessica Rene
Philippe Goupille
Guillermo Carvajal Alegria
机构：
[1] CHRU de Tours,Service de Rhumatologie
[2] Université de Tours,undefined
来源：
Inflammation Research | 2023年 / 72卷
关键词：
Tofacitinib; Upadacitinib; Baricitinib; Filgotinib; Rheumatoid arthritis; Efficacy; Predictive factors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1121 / 1132
页数：11
相关论文
共 50 条
  • [21] Thromboembolism with Janus Kinase (JAK) Inhibitors for Rheumatoid Arthritis: How Real is the Risk?
    Scott, Ian C.
    Hider, Samantha L.
    Scott, David L.
    DRUG SAFETY, 2018, 41 (07) : 645 - 653
  • [22] Risks and Benefits of Janus Kinase Inhibitors in Rheumatoid Arthritis - Past, Present, and Future
    Singh, Jasvinder A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (04): : 387 - 389
  • [23] Effect of different Janus Kinase Inhibitors on synovial Fibroblasts of Patients with Rheumatoid Arthritis
    Diller, Magnus
    Huelser, Marie-Lisa
    Rehart, Stefan
    Fleck, Martin
    Neumann, Elena
    Mueller-Ladner, Ulf
    INTERNIST, 2018, 59 : S7 - S8
  • [24] RISK OF VENOUS THROMBOEMBOLISM WITH JANUS KINASE INHIBITORS IN RHEUMATOID ARTHRITIS: A SYSTEMATIC REVIEW
    Baek, J.
    Huang, Y.
    Aparasu, R. R.
    Li, J.
    VALUE IN HEALTH, 2024, 27 (06) : S376 - S376
  • [25] Risk of venous thromboembolism with janus kinase inhibitors in rheumatoid arthritis: A systematic review
    Baek, Jiyoon
    Huang, Yinan
    Bruera, Sebastian
    Aparasu, Rajender R.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 298 - 298
  • [26] SURVIVAL ON JANUS KINASE INHIBITORS VERSUS OTHER ADVANCED THERAPIES IN RHEUMATOID ARTHRITIS
    Bakhtiar, N.
    Gray, L.
    Bilgrami, S. M.
    Ottewell, L.
    Wood, F.
    Bukhari, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1324 - 1325
  • [27] Epigenetic targets of Janus kinase inhibitors are linked to genetic risks of rheumatoid arthritis
    Tsuchiya, Haruka
    Ota, Mineto
    Takahashi, Haruka
    Hatano, Hiroaki
    Ogawa, Megumi
    Nakajima, Sotaro
    Yoshihara, Risa
    Okamura, Tomohisa
    Sumitomo, Shuji
    Fujio, Keishi
    INFLAMMATION AND REGENERATION, 2024, 44 (01)
  • [28] Comparison of Janus kinase inhibitors in the treatment of rheumatoid arthritis: a systemic literature review
    Jegatheeswaran, Jehanya
    Turk, Matthew
    Pope, Janet E.
    IMMUNOTHERAPY, 2019, 11 (08) : 737 - 754
  • [29] Real-world comparative study of the efficacy of Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study
    Hayashi, Shinya
    Tachibana, Shotaro
    Maeda, Toshihisa
    Yamashita, Mai
    Shirasugi, Iku
    Yamamoto, Yuzuru
    Yamada, Hirotaka
    Okano, Takaichi
    Nishimura, Keisuke
    Ueda, Yo
    Jinnno, Sadao
    Saegusa, Jun
    Yamamoto, Wataru
    Murata, Koichi
    Fujii, Takayuki
    Hata, Kenichiro
    Yoshikawa, Ayaka
    Ebina, Kosuke
    Etani, Yuki
    Yoshida, Naofumi
    Amuro, Hideki
    Hashimoto, Motomu
    Hara, Ryota
    Katayama, Masaki
    Okano, Tadashi
    Kuroda, Ryosuke
    RHEUMATOLOGY, 2023,
  • [30] Real-world study comparing the efficacy of Janus kinase inhibitors in patients with difficult-to-treat rheumatoid arthritis
    Hayashi, Shinya
    Nakano, Naoki
    Tsubosaka, Masanori
    Kamenaga, Tomoyuki
    Kuroda, Yuichi
    Matsumoto, Tomoyuki
    Yamada, Hirotaka
    Nishimra, Keisuke
    Ueda, Yo
    Saegusa, Jun
    Kuroda, Ryosuke
    CLINICAL RHEUMATOLOGY, 2024, : 3285 - 3292
12345